Aripiprazole, ARIPiprazole Lauroxil and Vaqta

• Generic Name: aripiprazole
• Dosage Forms: n.a.
• Other Brand Names: Abilify, Abilify Discmelt, Abilify Maintena, Aristada, Abilify MyCite, Aristada Initio

Used orally (as aripiprazole) and IM (as extended-release aripiprazole or aripiprazole lauroxil injection) for treatment of schizophrenia.

American Psychiatric Association (APA) considers most atypical antipsychotic agents first-line drugs for the management of the acute phase of schizophrenia (including first psychotic episodes).

Patients who do not respond to or tolerate one drug may be successfully treated with an agent from a different class or with a different adverse effect profile.

Immediate-release aripiprazole injection (no longer commercially available in the US) has been used IM for acute management of agitation in patients with schizophrenia.

Used orally alone or in conjunction with lithium or valproate for acute treatment of manic and mixed episodes associated with bipolar I disorder with or without psychotic features. Also used orally as monotherapy or as adjunctive therapy with lithium or valproate for maintenance treatment of bipolar I disorder.

Used IM (as extended-release aripiprazole injection [Abilify Maintena]) as monotherapy for maintenance treatment of bipolar I disorder.

Immediate-release aripiprazole injection (no longer commercially available in the US) has been used IM for acute management of agitation in patients with bipolar I disorder.

Used orally as adjunctive therapy to antidepressants for treatment of major depressive disorder.

Used orally for acute treatment of irritability associated with autistic disorder.

Used orally for treatment of Tourette's syndrome (Gilles de la Tourette’s syndrome).

• Generic Name: hepatitis a adult vaccine
• Dosage Forms: injection, suspension
• Other Brand Names: Havrix, Vaqta

Hepatitis is a serious disease caused by a virus. Hepatitis causes inflammation of the liver, vomiting, and jaundice (yellowing of the skin or eyes). Hepatitis can lead to liver cancer, cirrhosis, or death.

Hepatitis A is spread through contact with the stool (bowel movements) of a person infected with the hepatitis A virus. This usually occurs by eating food or drinking water that has become contaminated as a result of handling by an infected person.

The Vaqta is used to help prevent this disease in adults.

This vaccine works by exposing you to a small amount of the virus, which causes the body to develop immunity to the disease. This vaccine will not treat an active infection that has already developed in the body.

Vaccination with Vaqta is recommended for all adults who travel in certain areas of the world where hepatitis A is a common disease.

Other risk factors for hepatitis include: being a homosexual male; having chronic liver disease; using intravenous (IV) drugs; receiving treatment for hemophilia or other bleeding disorders; working in a research laboratory or around animals (especially monkeys) where you may be exposed to the hepatitis A virus; or being in an area where there has been an outbreak of hepatitis A.

Like any vaccine, the hepatitis A vaccine may not provide protection from disease in every person.